(Q84357377)

English

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation

scientific article published on 13 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

Everett E Vokes

11

object named as

Everett E Vokes

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

2

object named as

Daniel J Haraf

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tanguy Y Seiwert

5

object named as

Tanguy Y Seiwert

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Kerstin Stenson

6

object named as

Kerstin M Stenson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

4

object named as

Ezra E W Cohen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Mary Ellyn Witt

10

object named as

Mary Ellyn Witt

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Joseph John Salama

12

object named as

Joseph K Salama

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Victoria M Villaflor

9

object named as

Victoria M Villaflor

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1

object named as

Kevin S Choe

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Abhishek A Solanki

3

object named as

Abhishek Solanki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Elizabeth A Blair

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Louis Portugal

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

13 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

4671-4678

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose reirradiation of head and neck cancer with curative intent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant Chemoradiotherapy With Cisplatin, 5-Fluorouracil and Hydroxyurea in Poor-Prognosis Head and Neck Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of salvage treatment of the neck in patients with oral cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage re-irradiation for recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Reirradiation of recurrent head and neck cancers: external and/or interstitial radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Re-irradiation of head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Reirradiation of recurrent tumors in the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival after salvage reirradiation of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

The concurrent chemoradiation paradigm--general principles

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26084

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26084

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21671479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84357377&oldid=1743113084"